Vista division releases oral cancer screening system

Visual Solutions, a wholly owned subsidiary of Vista Dental Products, is focused on developing transformative life changing technologies for cancer screening, detection and intervention through the use of molecular markers.

Drawing on eight years of research, development and clinical studies, the company introduced the ESPyOC™ oral cancer screening system. ESPyOC™ is said to be a game-changer in the way the dental and medical community visualizes oral cancer. It is designed as a simple, cost-effective and noninvasive chairside test that provides immediate results for patients with suspicious lesions.

Utilizing a unique patent-pending biomarker approach, ESPyOC™ demonstrated 99 percent sensitivity and 85 percent specificity for oral cancer detection in mrore than 120 patients and accurately detected 79 percent of precancerous lesions.

For more information, visit vista-dental.com.

Related reading: The importance of oral cancer screening in the dental practice